Longitudinal In Vivo Characterization of the Streptozotocin-Induced Diabetic Mouse Model: Focus on Early Inner Retinal Responses
The goal of this study was to perform an extensive temporal characterization of the early pathologic processes in the…
Jim Datovech, President of LKC Technologies, Interviewed by CEOCFO Magazine
Interview Conducted By: Lynn Fosse, Senior Editor, CEOCFO Magazine CEOCFO: Mr. Datovech, what is the focus for LKC Technologies today? Mr. Datovech: We…
Assessing nonsedated handheld cone flicker electroretingram as a screening test in pediatric patients: comparison to sedated conventional cone flicker electroretinogram
The purpose of this study was to assess the RETeval (LKC Technologies, Gaithersburg, MD) handheld electroretinogram (ERG) device as a…
Hand-held, dilation-free, electroretinography in children under 3 years of age treated with vigabatrin
This is the first study to assess the utility of RETeval device in children under 3 years of age undergoing vigabatrin treatment…
Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy
This study features the RETeval device and aims to investigate the function and the corresponding neurovascular structures in patients with…
New CPT Codes for Visual Electrophysiology Testing in The U.S.
During calendar year 2018 the AMA and the American Academy of Ophthalmology conducted a RUC study of flash and pattern…
A nonhuman primate model of inherited retinal disease
In this study featuring the RETevet device, researchers have identified 4 related NHPs at the California National Primate Research Center with…
LKC to Stop Selling CMGS (color) and MGS-2 (white) Mini-Ganzfeld Stimulator Products in 2019
LKC Technologies officially announces that effective January 1, 2019, the CMGS (color) and MGS-2 (white) Mini-Ganzfeld Stimulator products will no longer be…
LKC Technologies, Inc. Announces Partnership with US Retina in GPO Program
Clinical Trial Provides Enhanced Normative Data for the RETeval Device GAITHERSBURG, MD, October 5, 2017 – LKC Technologies is announcing…
Supernormal Flicker ERGs in Eyes With Central Retinal Vein Occlusion: Clinical Characteristics, Prognosis, and Effects of Anti-VEGF Agent
The purpose of the study was to determine the clinical characteristics, prognosis, and effect of anti-vascular endothelial growth factor (VEGF)…
LKC Technologies, Inc. Announces the Availability of Integrated Normative Data on its RETeval® Device
LKC Technologies is proud to announce the launch of the new UTAS systems at ARVO 2019 in Vancouver, Canada. The new…
Evaluation of light- and dark-adapted ERGs using a mydriasis-free, portable system: clinical classifications and normative data
The purpose of this study was to determine the intra-visit reliability and diagnostic capability of a handheld, mydriasisfree ERG, RETeval…
Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to